Welcome to our dedicated page for Cardinal Health SEC filings (Ticker: CAH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cardinal Health, Inc. (NYSE: CAH) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Cardinal Health is an Ohio corporation whose common shares trade on the New York Stock Exchange under the symbol CAH, as noted in multiple Form 8-K filings. These documents give investors detailed insight into the company’s financial condition, governance, capital structure, and material events.
Cardinal Health regularly files Form 8-K current reports to announce significant developments. Recent 8-K filings include disclosures about quarterly and annual financial results, updates to fiscal 2026 non-GAAP earnings per share outlook, entry into material definitive agreements such as credit facilities and receivables purchase amendments, public offerings of notes to help fund acquisitions like Solaris Health, and the completion of those offerings. Other 8-Ks document matters such as the 2025 Annual Meeting of Shareholders and voting results on director elections, say-on-pay, and auditor ratification.
The company’s definitive proxy statement on Schedule 14A (DEF 14A) offers extensive information on corporate governance, Board composition, executive compensation, and shareholder voting items. Cardinal Health’s proxy materials describe its strategic priorities, fiscal performance highlights, Board skills and refreshment, and engagement with shareholders.
Through Stock Titan, users can review Cardinal Health’s periodic and current reports and use AI-powered tools to summarize key points from lengthy filings. These tools help explain complex sections, highlight items such as non-GAAP metrics definitions, capital markets transactions, and credit agreements, and make it easier to track themes like Specialty growth, distribution network investments, and capital allocation. The filings page also surfaces relevant exhibits, including indentures, underwriting agreements, and amendments to financing arrangements, giving a structured view of Cardinal Health’s obligations and governance framework.
Cardinal Health Inc. reported an insider equity transaction by its Chief Legal/Compliance Officer. On 12/01/2025, the officer had 422 common shares disposed of in a transaction coded "F," which represents shares withheld to cover tax obligations related to restricted share units. The price used for the withholding was the closing share price of $212.26 on the prior business day.
After this tax withholding event and an adjustment for shares transferred under a domestic relations order, the officer beneficially owned 34,427 common shares directly. The filing notes that these share withholdings are administrative in nature and tied to equity compensation rather than an open-market sale.
Cardinal Health reported a routine insider transaction by the CEO of its PSS segment. On 12/01/2025, 551 common shares of Cardinal Health were withheld at a price of $212.26 per share to cover the executive’s tax obligations related to restricted share units. After this tax withholding, the reporting person directly beneficially owns 52,877 common shares of Cardinal Health.
Cardinal Health Inc. reported an insider share transaction by its Chief Accounting Officer. On 12/01/2025, the officer had 61 common shares withheld and disposed of to cover tax obligations related to restricted share units, at a reference price of $212.26 per share. After this tax-related withholding, the officer beneficially owned 3,495 Cardinal Health common shares directly. The filing is administrative in nature and reflects routine equity compensation and associated tax withholding.
Cardinal Health Inc. executive reports routine share withholding for taxes. The CEO of the GMPD segment filed a Form 4 reporting that on 12/01/2025, 595 Cardinal Health common shares were withheld at a price of $212.26 per share to cover tax obligations related to restricted share units. After this transaction, the reporting person beneficially owned 25,490 common shares directly. The filing notes that this was a non-open-market transaction classified under code "F," meaning it reflects shares withheld by the company rather than a discretionary sale in the market.
Cardinal Health (CAH) disclosed a director equity grant on a Form 4. On 11/05/2025, a director acquired 1,067 restricted share units (Transaction Code A) at a stated price of $0. These RSUs will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Following this award, the director beneficially owned 2,116 common shares, held directly. This filing reflects routine director compensation in equity and does not indicate an open-market purchase or sale.
Cardinal Health (CAH) reported an insider equity grant on a Form 4. A director acquired 1,067 common shares on 11/05/2025 via a restricted share unit award at $0. Following this grant, the director beneficially owns 2,116 shares, held directly.
The restricted share units will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier.
Cardinal Health (CAH) director reported an equity award. On 11/05/2025, the reporting person acquired 1,067 restricted share units at no cost. The award will vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs earlier. Following this grant, the director beneficially owned 7,536 common shares directly.
Cardinal Health (CAH) director reported a routine equity grant on 11/05/2025. The filing shows an acquisition of 1,067 common shares at $0, reflecting a grant of restricted share units. Following the transaction, the director’s beneficial ownership stands at 27,624 shares, held directly.
The restricted share units will vest on November 5, 2026, or if the 2026 Annual Meeting of Shareholders occurs earlier, on the meeting date.
Cardinal Health (CAH) reported an insider equity award. A company director acquired 1,702 common shares on 11/05/2025 via an award priced at $0, reflecting a grant of restricted share units. Following the transaction, the director beneficially owns 64,194 shares directly.
The restricted share units are scheduled to vest on November 5, 2026, or on the date of the 2026 Annual Meeting of Shareholders if that meeting occurs before November 5, 2026.
Cardinal Health (CAH) reported an insider equity grant. A director acquired 1,067 restricted share units on November 5, 2025, recorded at $0 per unit. Following the transaction, the reporting person beneficially owns 22,868 common shares, held directly. The RSUs will vest on November 5, 2026, or, if the 2026 Annual Meeting of Shareholders occurs before that date, they will vest on the meeting date.